Research Insight
AstraZeneca and Incyte announce new lung cancer clinical trial collaboration
AstraZeneca and Incyte Corporation today announced a new collaboration to evaluate the efficacy and safety of Incyte’s Janus-associated kinase (JAK) 1 inhibitor, INCB39110, in combination with AstraZeneca’s next generation epidermal growth factor receptor (EGFR) inhibitor, Tagrisso® (osimertinib). The combination...
Research Insight
AstraZeneca partners with peers and academia to establish translational research fund
AstraZeneca together with GlaxoSmithKline and Johnson & Johnson has partnered with three world-class universities, Imperial College London, the University of Cambridge and University College London (UCL), to create the Apollo Therapeutics Fund. This pioneering new consortium aims to convert...
Research Insight
UMMS study shows Google Glass effective tool for toxicology consult in ER
Researchers at UMass Medical School have found that Google Glass, a head-mounted streaming audio/video device, may be used to effectively extend bed-side toxicology consults to distant health care facilities to diagnose and manage patients with suspected cases of poisoning....
Articles
Working Towards a Healthier Future
About one to two of every 1000 babies are born with hydrocephalus, a condition in which too much fluid builds up inside the skull. There is no cure, but treatment may provide long-term relief. Four-year-old Ananya Shah was diagnosed...
Research Insight
ASCO hail cancer immunotherapy as clinical cancer advance of the year
In their just-released Clinical Cancer Advances 2016: ASCO’s Annual Report on Progress Against Cancer the American Society of Clinical Oncology (ASCO) has today hailed cancer immunotherapy as the top cancer advance of the year. “No...
Research Insight
Study Finds High Proportion of Advanced Breast Cancers in sub-Saharan Africa
In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d’Ivoire and Republic of Congo are detected only after they’ve become advanced. The study, by American Cancer Society...
Research Insight
Cancer Remains Leading Cause of Death in U.S. Hispanics
While cancer is the second leading cause of death overall in the United States, it remains the leading cause of death among U.S. Hispanics. The finding comes from “Cancer Statistics for Hispanics/Latinos,” a comprehensive report produced every three years...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read